Seven Eight Capital LP Invests $433,000 in Azenta, Inc. (NASDAQ:AZTA)

Seven Eight Capital LP purchased a new stake in shares of Azenta, Inc. (NASDAQ:AZTAFree Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 8,234 shares of the company’s stock, valued at approximately $433,000.

Several other institutional investors have also recently bought and sold shares of the business. Hantz Financial Services Inc. acquired a new stake in shares of Azenta in the second quarter valued at $30,000. Principal Securities Inc. acquired a new stake in Azenta in the 4th quarter valued at about $36,000. Benjamin F. Edwards & Company Inc. bought a new position in shares of Azenta in the first quarter worth about $38,000. BI Asset Management Fondsmaeglerselskab A S acquired a new position in shares of Azenta during the first quarter worth approximately $49,000. Finally, Lazard Asset Management LLC bought a new stake in shares of Azenta during the first quarter valued at approximately $130,000. Institutional investors own 99.08% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have issued reports on the company. Evercore ISI upped their price objective on Azenta from $52.00 to $53.00 and gave the stock an “in-line” rating in a report on Tuesday, July 2nd. Needham & Company LLC reaffirmed a “buy” rating and set a $69.00 price target on shares of Azenta in a research note on Wednesday, August 7th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat, Azenta presently has a consensus rating of “Hold” and an average target price of $67.00.

Read Our Latest Stock Report on Azenta

Azenta Stock Performance

AZTA opened at $49.27 on Monday. The company has a fifty day moving average price of $52.36 and a two-hundred day moving average price of $53.85. The firm has a market capitalization of $2.66 billion, a PE ratio of -18.18 and a beta of 1.47. Azenta, Inc. has a 52 week low of $44.00 and a 52 week high of $69.16.

Azenta (NASDAQ:AZTAGet Free Report) last released its quarterly earnings data on Tuesday, August 6th. The company reported $0.16 EPS for the quarter, beating analysts’ consensus estimates of $0.07 by $0.09. Azenta had a positive return on equity of 0.89% and a negative net margin of 23.66%. The business had revenue of $173.00 million during the quarter, compared to the consensus estimate of $166.14 million. During the same quarter in the prior year, the company posted $0.13 earnings per share. The firm’s revenue was up 4.2% on a year-over-year basis. Equities analysts forecast that Azenta, Inc. will post 0.33 EPS for the current year.

Azenta Company Profile

(Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Featured Stories

Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTAFree Report).

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.